Vacunación frente a la neumonía adquirida en la comunidad del adulto. Posicionamiento del Grupo de Neumoexpertos en Prevención

Redondo, Esther; Rivero, I; Vargas, Diana; Mascarós, Enrique; Díaz-Maroto, J L; Linares, Manuel; Valdepérez, J.; Â, Gil; Molina, Jesús; Jimeno, I; Ocaña, Daniel; Martinón-Torres, Federico

doi:10.1016/j.semerg.2016.07.009

Cited by 9 publications

(3 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…En todo caso, como siempre se ha dicho, las medidas de prevención CV deben estar presididas por la adopción, o mantenimiento en su caso, de un estilo de vida saludable, con especial atención a la dieta mediterránea, ejercicio físico y abstención de hábitos tóxicos 59 . Es importante que los pacientes con ECV se mantengan al día con las vacunas, incluida la vacuna antineumocócica, dado el mayor riesgo de infección bacteriana secundaria con la COVID-19 60 .…”

Section: El Futuro De La Enfermedad Cardiovascular Tras La Covid-19unclassified

COVID-19 y enfermedad cardiovascular y renal: ¿Dónde estamos? ¿Hacia dónde vamos?

Pallarés-Carratalá

Górriz-Zambrano²,

Ariño

et al. 2020

Medicina de Familia. SEMERGEN

View full text Add to dashboard Cite

show abstract

Section: El Futuro De La Enfermedad Cardiovascular Tras La Covid-19unclassified

COVID-19 y enfermedad cardiovascular y renal: ¿Dónde estamos? ¿Hacia dónde vamos?

Pallarés-Carratalá

Górriz-Zambrano²,

Ariño

et al. 2020

Medicina de Familia. SEMERGEN

View full text Add to dashboard Cite

show abstract

“…In 75%-80% of cases, CAP is diagnosed in PC [65,70] and Streptococcus pneumoniae is the cause of two-thirds of these cases. Invasive forms of pneumococcal disease (IPD) are less common, occur in patients with certain risk factors and have high mortality rates [70].…”

Section: How Much Of Infection In the Elderly Is Resolved In Primary mentioning

confidence: 99%

The situation of infection in the elderly in Spain: a multidisciplinary opinion document

Bouza

Brenes²,

Domingo³

et al. 2020

Rev Esp Quimioter

View full text Add to dashboard Cite

Infection in the elderly is a huge issue whose treatment usually has partial and specific approaches. It is, moreover, one of the areas where intervention can have the most success in improving the quality of life of older patients. In an attempt to give the widest possible focus to this issue, the Health Sciences Foundation has convened experts from different areas to produce this position paper on Infection in the Elderly, so as to compare the opinions of expert doctors and nurses, pharmacists, journalists, representatives of elderly associations and concluding with the ethical aspects raised by the issue. The format is that of discussion of a series of pre-formulated questions that were discussed by all those present. We begin by discussing the concept of the elderly, the reasons for their predisposition to infection, the most frequent infections and their causes, and the workload and economic burden they place on society. We also considered whether we had the data to estimate the proportion of these infections that could be reduced by specific programmes, including vaccination programmes. In this context, the limited presence of this issue in the media, the position of scientific societies and patient associations on the issue and the ethical aspects raised by all this were discussed.

show abstract

“…According to a study from the United States, vaccination prevented a significant number of influenza-related illnesses and reduced the burden of hospitalizations and death in 2017-2018, despite the low efficacy of influenza vaccines [5]. In addition, vaccination against pneumonia in adulthood reduced the burden of community-acquired pneumonia and its associated complications [6]. However, many countries face multiple challenges including vaccine shortages, a lack of public awareness, insufficient vaccine demand, and failure to integrate influenza vaccines into the national immunization program, which lead to suboptimal vaccination coverage [7][8][9][10].…”

Section: Introductionmentioning

confidence: 99%

Public Interest in Distribution and Determinants of Influenza and Pneumonia Vaccination during the COVID-19 Pandemic: An Infodemiology and Cross-Sectional Study from China

Gong

Zhang

et al. 2021

Vaccines

View full text Add to dashboard Cite

Background: Following the COVID-19 pandemic, global interest in influenza vaccines and pneumonia vaccines has increased significantly. We aimed to examine public interest in and actual market circulation of influenza and pneumonia vaccines before and after the initial outbreak of COVID-19 and estimate the coverage and determinants of influenza and pneumonia vaccination uptake following the COVID-19 pandemic. Methods: We obtained search volume data for vaccines using the Baidu search index and collected the numbers of vaccines issued from the National Institutes for Food and Drug Control. We also conducted a cross-sectional survey among 3346 adult residents to evaluate the coverage and determinants of influenza and pneumonia vaccination uptake in the Yangtze River delta, China, from 29 January to 4 February 2021. Results: Public searches and the number of vaccines issued for the influenza vaccines and pneumonia vaccines obviously increased after the initial outbreak of COVID-19. In the total sample, 12.5% were vaccinated against influenza, and 21.5% had at least one family member vaccinated against pneumonia. A minority of participants perceived that they were highly or very highly susceptible to influenza (15.9%) and COVID-19 (6.7%). A range of socio-economic factors and perceived susceptibility to COVID-19 were associated with influenza and pneumonia vaccination uptake. Conclusions: Public interest in and issued volumes of influenza and pneumonia vaccines increased nationally following the COVID-19 pandemic. Perceptions of high susceptibility to COVID-19 were associated with the uptake of the influenza and pneumonia vaccines. Targeted interventions were needed to improve vaccination coverage.

show abstract

Vacunación frente a la neumonía adquirida en la comunidad del adulto. Posicionamiento del Grupo de Neumoexpertos en Prevención

Cited by 9 publications

References 47 publications

COVID-19 y enfermedad cardiovascular y renal: ¿Dónde estamos? ¿Hacia dónde vamos?

COVID-19 y enfermedad cardiovascular y renal: ¿Dónde estamos? ¿Hacia dónde vamos?

The situation of infection in the elderly in Spain: a multidisciplinary opinion document

Public Interest in Distribution and Determinants of Influenza and Pneumonia Vaccination during the COVID-19 Pandemic: An Infodemiology and Cross-Sectional Study from China

Contact Info

Product

Resources

About